Patchy Hair Loss and Scalp Scale in a Child

A child develops enlarging patches of hair loss with scale, broken hairs, itching, and posterior cervical nodes. A sibling has a scaly scalp, but the first visit was labeled alopecia areata without fungal testing. The combination favors tinea capitis, while hair pulling, traction, psoriasis, seborrheic dermatitis, and autoimmune alopecia still require comparison.

Case focus#

The decision is whether examination and mycologic sampling support prompt systemic antifungal treatment, since topical therapy alone does not reliably clear infected hair shafts. The team must also identify an inflammatory kerion, secondary bacterial infection, or scarring risk while avoiding unnecessary exclusion from school.

This analysis concentrates on calibration. It compares plausible explanations, asks which observations genuinely discriminate among them, and keeps the working diagnosis open to revision as new evidence arrives.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this tinea capitis with patchy alopecia analysis, the working frame must remain broad enough to compare Tinea capitis, Alopecia areata, Traction alopecia, Hair-pulling disorder without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: A pediatric clinic with scalp dermoscopy, fungal microscopy and culture, access to systemic antifungal monitoring, dermatology consultation, and school-health communication.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

• Boggy tender kerion or pustular plaque: A painful raised inflammatory mass, pustules, crust, and easy hair extraction indicate a kerion. Delayed systemic antifungal care increases scarring risk, while routine incision can worsen injury.
• Fever spreading erythema or systemic illness: Fever, rapidly expanding redness, fluctuance beyond the follicular plaque, lymphangitis, or toxic appearance suggests bacterial superinfection or another invasive process requiring prompt culture and treatment.
• Shiny scarred scalp or permanent follicle loss: Loss of follicular openings, atrophy, shiny skin, or expanding scarring means this is not uncomplicated nonscarring alopecia and requires rapid dermatology assessment and often tissue diagnosis.
• Immunocompromise or extensive refractory disease: Widespread infection, repeated treatment failure, systemic immune suppression, or infection beyond scalp and superficial skin changes organism risk, drug choice, monitoring, and the threshold for referral.

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Tinea capitis#

What supports it. Scale, broken hairs at different lengths, black dots, itching, posterior cervical nodes, household spread, and comma or corkscrew hairs support dermatophyte infection of the shaft.

What argues against it or keeps uncertainty open. A completely smooth patch without scale or broken hairs, normal nodes, and characteristic exclamation hairs makes tinea less likely, though treated infection can be subtle.

Discriminating next step. Pluck broken hairs and scrape scale from the active edge for microscopy and fungal culture before treatment when possible; do not delay systemic therapy for a classic kerion.

Alopecia areata#

What supports it. Abrupt smooth round patches, preserved follicular openings, exclamation-point hairs, nail pitting, and no scale or inflammation support autoimmune alopecia.

What argues against it or keeps uncertainty open. Diffuse scale, pruritus, tender nodes, household cases, and fungal elements argue strongly against alopecia areata as the only process.

Discriminating next step. Use dermoscopy to inspect the border and nails; perform fungal testing when scale or breakage creates overlap before applying topical immune treatment.

Traction alopecia#

What supports it. Hair loss follows tight braids, ponytails, extensions, or repeated edge tension, with perifollicular change and a distribution matching the style.

What argues against it or keeps uncertainty open. Posterior scalp patches, lymphadenopathy, scale across hairs, and spread to siblings are not explained by traction.

Discriminating next step. Ask permission to examine beneath the style, map areas of tension and retained fringe, stop the injurious practice, and reassess for regrowth and signs of scarring.

Hair-pulling disorder#

What supports it. Irregular patches with hairs of many lengths, sparing of difficult-to-reach areas, negative fungal studies, and a history of pulling or stress can support a hair-pulling disorder.

What argues against it or keeps uncertainty open. Contagious household disease, lymph nodes, uniform shaft breakage with scale, or fungal elements points away from self-induced loss.

Discriminating next step. Use dermoscopy and a gentle private interview with the child and caregiver, avoiding confrontation; behavioral-health support follows when the pattern and history align.

Psoriasis or seborrheic dermatitis#

What supports it. Diffuse greasy or sharply demarcated scale, involvement behind ears or elsewhere on skin, and hairs that remain intact support an inflammatory scalp dermatosis.

What argues against it or keeps uncertainty open. Focal alopecia with black dots, tender nodes, a kerion, or positive fungal microscopy is not explained by seborrheic dermatitis alone.

Discriminating next step. Examine nails, ears, face, elbows, and the entire scalp, then use fungal sampling before anti-inflammatory monotherapy when focal hair loss is present.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

• Scalp hair node and skin examination. Document scale, broken hairs, black dots, pustules, bogginess, follicular openings, scarring, cervical nodes, nail change, and similar lesions on household contacts. Interpretation: Broken scaly hairs with nodes supports tinea; smooth nonscarring patches suggest alopecia areata; loss of follicular openings requires a scarring-alopecia branch.
• Dermoscopy of affected and border hairs. Magnification can identify comma, corkscrew, zigzag, exclamation, tapered, and broken-hair patterns and target the most diagnostic sampling site. Interpretation: Comma or corkscrew hairs increase fungal probability; exclamation hairs and yellow dots favor alopecia areata; variable broken lengths can support pulling or traction.
• Fungal microscopy and culture sampling. Microscopy can provide rapid support, while culture identifies the organism and informs treatment and outbreak advice. Samples should include shaft material, not surface scale alone. Interpretation: Visible hyphae or spores supports immediate antifungal therapy; a positive culture confirms organism. A negative sample after treatment or poor collection requires reassessment if the phenotype remains strong.
• Household exposure and hair-practice history. Shared combs, hats, close contact, pets, school clusters, protective styles, chemicals, and prior topical steroid use separate infection from mechanical or inflammatory causes. Interpretation: A symptomatic sibling or shared fomite increases transmission probability. A distribution matching chronic tension supports traction but does not exclude simultaneous infection.
• Bacterial culture or biopsy for atypical inflammation. Purulent drainage, spreading cellulitis, scarring, treatment failure, or an atypical plaque may require bacterial culture or scalp biopsy rather than repeated empiric antifungals. Interpretation: A bacterial pathogen adds targeted therapy; biopsy can reveal scarring inflammation, psoriasis, or another diagnosis when fungal studies and response are discordant.

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

Dermoscopy shows comma-shaped and broken hairs, and scale is sampled from the active margin before treatment. Fungal culture later identifies a dermatophyte that informs agent selection. A boggy tender plaque develops without systemic instability, prompting dermatology review for inflammatory management and close monitoring of regrowth.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

• Use a systemic antifungal matched to organism and child factors. Hair-shaft infection is not eradicated by topical therapy alone. Agent and duration reflect likely species, culture, age, liver and interaction risks, formulation access, and current guidance.
• Reduce surface spores without promising topical cure. Adjunctive sporicidal shampoo for the child and sometimes close contacts can reduce transmission, but caregivers should not substitute shampoo for the prescribed oral course.
• Protect a kerion from avoidable procedures. Start systemic treatment promptly, control pain, and obtain dermatology input for severe inflammation. Incision and drainage is avoided unless a true bacterial abscess is established.
• Address household and school transmission proportionately. Avoid sharing combs, hats, pillows, and clippers, clean grooming tools, examine symptomatic contacts, and follow local school guidance without prolonged unnecessary exclusion.
• Verify adherence toxicity and regrowth. At a fixed review, assess dose actually taken, formulation tolerance, scale, nodes, hair breakage, and new growth. Persistent disease triggers culture review, adherence barriers, resistance, or an alternative diagnosis.

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Explain to the caregiver that fungal infection can break hair without reflecting hygiene failure, that oral treatment is usually needed, and that culture may take time. Review household comb and hat practices, medicine duration, adverse-effect reporting, and realistic expectations for visible regrowth.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

• Return promptly for fever, spreading redness, severe tenderness, pus beyond the plaque, eyelid swelling, or a rapidly enlarging boggy mass.
• Contact dermatology for shiny scarred skin, loss of follicular openings, progressive permanent loss, or no clinical response despite a verified full course.
• Bring all oral and topical products to follow-up so dose, formulation, steroid exposure, and interaction can be checked.
• Track fungal culture and organism identification to the prescribing clinician and communicate any treatment change directly to the caregiver.

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

Hair texture, protective styles, cultural hair practices, and unequal dermatology access can influence examination and misdiagnosis. Examine respectfully, ask before removing styles, provide affordable laboratory and treatment options, and avoid school policies that exceed current public-health recommendations.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

• Distinguishes fungal shaft infection from autoimmune, traction, pulling, and inflammatory scalp disorders through scale, hair morphology, nodes, and distribution.
• Samples both affected hairs and active-edge scale and understands the different timing and value of microscopy and culture.
• Recognizes a kerion as an inflammatory fungal complication that needs prompt systemic treatment and protection from unnecessary incision.
• Examines hair and protective styles respectfully across textures and asks before altering a style.
• Links organism-directed therapy, household control, formulation access, toxicity review, and objective regrowth.

Key takeaways#

• Patchy alopecia with scale, broken hairs, nodes, and household spread is tinea capitis until mycologic testing or the course shows otherwise.
• Oral antifungal treatment reaches infected hair shafts; shampoo is an adjunct for surface spores and transmission.
• A painful kerion and early scarring signs require faster action because delayed treatment can make hair loss permanent.